Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
13.24
-0.03 (-0.23%)
Dec 20, 2024, 4:00 PM EST - Market closed
Sotera Health Company Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for SHC stock have an average target of 16.5, with a low estimate of 13 and a high estimate of 20. The average target predicts an increase of 24.62% from the current stock price of 13.24.
Analyst Consensus: Buy
* Price targets were last updated on Nov 21, 2024.
Analyst Ratings
The average analyst rating for SHC stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $17 | Buy | Reiterates | $17 | +28.40% | Nov 21, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $18 → $20 | Strong Buy | Maintains | $18 → $20 | +51.06% | Nov 6, 2024 |
| Barclays | Barclays | Buy Maintains $14 → $17 | Buy | Maintains | $14 → $17 | +28.40% | Aug 6, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $17 | Buy | Reiterates | $17 | +28.40% | Aug 6, 2024 |
| Piper Sandler | Piper Sandler | Hold Initiates $13 | Hold | Initiates | $13 | -1.81% | May 21, 2024 |
Financial Forecast
Revenue This Year
1.11B
from 1.05B
Increased by 5.98%
Revenue Next Year
1.17B
from 1.11B
Increased by 5.40%
EPS This Year
0.70
from 0.18
Increased by 288.97%
EPS Next Year
0.80
from 0.70
Increased by 13.91%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.2B | 1.2B | 1.3B | |||
| Avg | 1.1B | 1.2B | 1.2B | |||
| Low | 1.1B | 1.1B | 1.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 10.7% | 10.5% | 12.9% | |||
| Avg | 6.0% | 5.4% | 6.2% | |||
| Low | 2.0% | 0.8% | 1.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.75 | 0.86 | 1.01 |
| Avg | 0.70 | 0.80 | 0.91 |
| Low | 0.67 | 0.70 | 0.78 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 314.2% | 23.0% | 26.9% |
| Avg | 289.0% | 13.9% | 13.7% |
| Low | 270.2% | -0.6% | -1.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.